Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$255.7 - $288.46 $562,540 - $634,612
2,200 Added 14.97%
16,900 $4.87 Million
Q3 2023

Oct 26, 2023

BUY
$218.65 - $271.46 $1.05 Million - $1.3 Million
4,800 Added 48.48%
14,700 $3.95 Million
Q2 2023

Aug 08, 2023

SELL
$214.27 - $253.37 $299,978 - $354,718
-1,400 Reduced 12.39%
9,900 $2.2 Million
Q1 2023

May 02, 2023

BUY
$225.79 - $275.2 $1.26 Million - $1.54 Million
5,600 Added 98.25%
11,300 $2.73 Million
Q4 2022

Jan 23, 2023

BUY
$229.03 - $291.01 $1.31 Million - $1.66 Million
5,700 New
5,700 $0

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Xr Securities LLC Portfolio

Follow Xr Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.